Discovery, clinical development, and therapeutic uses of bisphosphonates.
about
Recent developments in osteogenesis imperfectaN-phenacylthiazolium bromide reduces bone fragility induced by nonenzymatic glycationThe bisphosphonate alendronate improves the damage associated with trinitrobenzenesulfonic acid-induced colitis in ratsBisphosphonate-related osteonecrosis of the jaw: historical, ethical, and legal issues associated with prescribing.Bisphosphonate-related osteonecrosis of jaw (BRONJ): diagnostic criteria and possible pathogenic mechanisms of an unexpected anti-angiogenic side effectReveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclastsUse of bisphosphonates and reduced risk of colorectal cancer.Denosumab: A bone antiresorptive drugZoledronic Acid may reduce intraoperative bleeding in spinal tumors: a prospective cohort studyEuodia sutchuenensis Dode extract stimulates osteoblast differentiation via Wnt/β-catenin pathway activationAssociation between alendronate, serum alkaline phosphatase level, and heterotopic ossification in individuals with spinal cord injury.Effect of bisphosphonates on orthodontic tooth movement-an updateEstablishment of an Animal Model of Bisphosphonate-Related Osteonecrosis of the Jaws in Spontaneously Diabetic Torii Rats.Bisphosphonate therapy in multiple myeloma in preventing vertebral collapses: preliminary report.Management of age-related osteoporosis and prevention of associated fractures.Paget's Disease of Bone: A Review of Epidemiology, Pathophysiology and ManagementThe Prevention of Medication-related Osteonecrosis of the Jaw.Population pharmacokinetic and pharmacodynamic modeling for assessing risk of bisphosphonate-related osteonecrosis of the jaw.Metagenomic investigation of microbes and viruses in patients with jaw osteonecrosis associated with bisphosphonate therapy.Associations between Systemic Markers of Bone Turnover or Bone Mineral Density and Anti-Resorptive Agent-Related Osteonecrosis of the Jaw in Patients Treated with Anti-Resorptive Agents.The use of bisphosphonates in cancer patients.Bisphosphonate treatment in the oim mouse model alters bone modeling during growthComplexation of bisphosphonates with ytterbium(III): application of phosphate and ATP detection assay based on Yb(3+)-pyrocatechol violet.An Insight in to Paget's Disease of Bone.Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease.Pharmacologic augmentation of implant fixation in osteopenic bone.Zoledronic acid enhances lipopolysaccharide-stimulated proinflammatory reactions through controlled expression of SOCS1 in macrophages.Geranylgeranyl diphosphate depletion inhibits breast cancer cell migration.Impact of Bisphosphonate on Orthodontic tooth movement and osteoclastic count: An Animal Study.Administration of bisphosphonate (ibandronate) impedes molar tooth movement in rabbits: A radiographic assessment.Geranylgeranyl diphosphate synthase inhibition induces apoptosis that is dependent upon GGPP depletion, ERK phosphorylation and caspase activation.Effects of naringin on the proliferation and osteogenic differentiation of human amniotic fluid-derived stem cells.Trinuclear Metal Clusters in Catalysis by Terpenoid Synthases.Osteoprotegerin plasma levels are strongly associated with polymorphisms in human homologue of the mouse progressive ankylosis (ANKH) gene.Panax notoginseng saponins promote osteogenic differentiation of bone marrow stromal cells through the ERK and P38 MAPK signaling pathways.Maohuoside A promotes osteogenesis of rat mesenchymal stem cells via BMP and MAPK signaling pathways.Achyranthes bidentata saponins promote osteogenic differentiation of bone marrow stromal cells through the ERK MAPK signaling pathway.
P2860
Q26781674-D759CD4C-289A-469C-A930-85DFBC77508CQ28541226-00982267-BD5B-4364-B82B-234513D5A674Q28569481-6CF55DFE-1843-4265-A87E-56C1B5EF960CQ33885770-538CA8CF-F2C4-483A-9D77-E7413347195BQ34322430-134DE80F-C4DB-45B6-AB0C-E276DE4FDD3FQ34574959-C35F7DA9-EE57-45E4-8F5C-EF43D54E7246Q34877539-C69A334B-55EC-4890-B62F-82C28320417EQ34980675-99228552-5CFF-441E-B614-F8EBD11DFBEFQ35050733-CA9C91C4-E0D9-4089-AD97-DD679289B0F0Q35152942-7E3EFBE6-D907-478C-A30D-016981702D24Q35418599-B55DD20E-6ED6-4F6B-933C-96E504F715C3Q35622970-CBCDC077-A752-429E-9080-D4A64EBEA0B2Q35867167-77A1054A-9F53-465D-9568-E949B628E11CQ35886257-52294BEB-6C1D-406D-8281-D75FEF21D92DQ35919125-1E54D7CF-F78D-4A01-84C5-124AADFBE378Q36059397-DBBE8DF1-746A-4C2C-B205-0372538D5FADQ36292333-2CB13867-C7DA-48F5-9A49-BFA493B118CDQ36532868-B52AA653-4272-43D9-8A8B-4D426D666FBBQ36567433-C9407C04-BA97-4C7A-8468-AF937117BE96Q36753894-6F835FB3-A9B9-4F25-BABA-41863D3E13BBQ36846894-968100B3-842F-4EB3-8013-F2315DFD961CQ37079651-B24A339B-B7E7-420D-B506-BDBE49E01904Q37438653-0D8643BD-32A9-4B50-B97E-351E27E0F7B0Q37636342-AAC57499-9B96-4DF8-9E53-F5693FD15100Q38104993-AEE7A5B4-E61D-4D1B-86A7-9E36B19F4CD0Q38167678-252AA1B4-BC1F-4676-86C1-186C8949A09CQ39122419-503E2AA6-4CB4-40DC-AF53-4DC4B67AA261Q39702852-AAEFE443-FA50-4B42-9813-8BEE91058A51Q40035895-20200AB8-5591-43B2-94AF-C1220BB42ABDQ40221486-79BF4008-F3E8-40D1-A3C3-0BCD1CF967C1Q42292367-A106C83E-9AAB-4385-942A-FFBFD53A45B6Q42705272-774ACBE8-5D50-4C46-A5CB-0A95663547B7Q42729229-A9EED415-DC7F-4396-A5F7-E150B7812615Q47828404-0E5A630C-A620-499F-B14A-4679823EF83BQ50527466-1256EE12-37FA-4FAF-B7EF-9C5B18BF8DBDQ50531471-BA395E84-E956-4929-8A6D-467117E917EAQ54360267-D3FFE290-D3CA-4DF5-9FFD-D8DC2E2905CE
P2860
Discovery, clinical development, and therapeutic uses of bisphosphonates.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Discovery, clinical development, and therapeutic uses of bisphosphonates.
@ast
Discovery, clinical development, and therapeutic uses of bisphosphonates.
@en
type
label
Discovery, clinical development, and therapeutic uses of bisphosphonates.
@ast
Discovery, clinical development, and therapeutic uses of bisphosphonates.
@en
prefLabel
Discovery, clinical development, and therapeutic uses of bisphosphonates.
@ast
Discovery, clinical development, and therapeutic uses of bisphosphonates.
@en
P2860
P356
P1476
Discovery, clinical development, and therapeutic uses of bisphosphonates.
@en
P2093
Angelo A Licata
P2860
P304
P356
10.1345/APH.1E357
P407
P577
2005-03-08T00:00:00Z